---
title: NASH therapies head toward landmark approval
description: NASH therapies head toward landmark approval
---

[PathAI Publications ](https://www.pathai.com/publications)

# [NASH therapies head toward landmark approval](https://www.pathai.com/publications/nash-therapies-head-toward-landmark-approval)

 Written by [Admin](https://www.pathai.com/publications/author/admin) | May 4, 2023 4:00:00 AM

## Article

**Drugs targeting metabolic drivers of fatty liver disease show promise at resolving inflammation, reducing damage and reversing fibrosis. **

On 19 May, advisors to the US Food and Drug Administration (FDA) will meet virtually to discuss whether the antifibrotic benefits of a drug called Ocaliva from Intercept Pharmaceuticals outweigh the toxicity risks for patients with this common fatty liver disease. A full regulatory decision is expected a month later. Approval of a second drug, resmetirom from Madrigal Pharmaceuticals, could soon follow.

[View Publication](https://www.nature.com/articles/s41587-023-01787-8#:~:text=Drugs%20targeting%20metabolic%20drivers%20of,reducing%20damage%20and%20reversing%20fibrosis)

[View full post](https://www.pathai.com/publications/nash-therapies-head-toward-landmark-approval)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Admin"
  },
  "dateModified" : "2025-07-24T18:57:46.933Z",
  "datePublished" : "2023-05-04T04:00:00Z",
  "headline" : "NASH therapies head toward landmark approval",
  "image" : {
    "@type" : "ImageObject",
    "height" : 60,
    "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
    "width" : 60
  },
  "mainEntityOfPage" : "https://www.pathai.com/publications/nash-therapies-head-toward-landmark-approval",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "PathAI Publications"
  }
}
```